Earlier, we showed that streptozocin (STZ)-induced type 1 diabetes in rats leads to the development of painful peripheral diabetic neuropathy (PDN) manifested as thermal hyperalgesia and mechanical allodynia accompanied by significant enhancement of T-type calcium currents (T-currents) and cellular excitability in medium-sized dorsal root ganglion (DRG) neurons. Here, we studied the in vivo and in vitro effects of gene-silencing therapy specific for the Ca V 3.2 isoform of T-channels, on thermal and mechanical hypersensitivities, and T-current expression in small-and medium-sized DRG neurons of STZ-treated rats. We found that silencing of the T-channel Ca V 3.2 isoform using antisense oligonucleotides, had a profound and selective anti-hyperalgesic effect in diabetic rats and is accompanied by significant down-regulation of T-currents in DRG neurons. Anti-hyperalgesic effects of Ca V 3.2 antisense oligonucleotides in diabetic rats were similar in models of rapid and slow onset of hyperglycemia following intravenous and intraperitoneal injections of STZ, respectively. Furthermore, treatments of diabetic rats with daily insulin injections reversed T-current alterations in DRG neurons in parallel with reversal of thermal and mechanical hypersensitivities in vivo. This confirms that Ca V 3.2 T-channels, important signal amplifiers in peripheral sensory neurons, may contribute to the cellular hyperexcitability that ultimately leads to the development of painful PDN. Ó
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Introduction
One of the most common complications of early-onset diabetes mellitus (type 1) is peripheral neuropathy, which occurs in about 66% of patients [11] . A prominent feature of peripheral diabetic neuropathy (PDN) is neuropathic pain, which typically involves the extremities and is characterized in its early phase by hyperalgesia and/or allodynia to mechanical or thermal stimuli. Current therapies for painful PDN are largely inadequate and often are associated with serious side effects.
Although the precise cellular mechanisms of hyperalgesia and allodynia in PDN remain poorly understood, some promising clues have emerged. It has been suggested, for example, that the remodeling of voltage-and ligand-gated ion channels, which can increase excitability of the sensory neurons, has a critical function in hyperalgesia and allodynia [5, 7, 39] . Of particular interest with regard to this study are the findings suggesting that the neuronal T-type, low-voltage-activated Ca 2+ channels (T-channels) are important in modulating both acute and chronic peripheral pain signals, thus contributing to the development of acute and chronic pain conditions in vivo [30, 36, 37] . We have shown that type 1 diabetes induced in rats by streptozocin (STZ) leads to the development of painful PDN, which is manifested as thermal hypersensitivity and mechanical allodynia. PDN is accompanied by significant increases in T-currents and cellular excitability recorded from the medium-sized dorsal root ganglion (DRG) neurons [18] . Although an increase in the excitability of sensory neurons often leads to pathologically exaggerated pain perception, such as increased responses to painful stimuli (hyperalgesia) or responses to ordinarily innocuous stimuli as though they were painful (allodynia) [5], a possible relationship between PDN and the up-regulation of T-channels in sensory neurons remains to be established. To determine the importance of Tchannel modulation in STZ-induced PDN, we examined the in vivo and in vitro effects of gene-silencing therapy specific for the most
